Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Daisuke,Shintani

第一单位： Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.

作者： Daisuke,Shintani ^[1] ; Hiroyuki,Yoshida ^[2] ; Akira,Yabuno ^[1] ; Keiichi,Fujiwara ^[1]

作者单位： Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan. ^[1] Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan hiro_y@saitama-med.ac.jp. ^[2]

关键词 Older patients bevacizumab chemotherapy toxicity ovarian cancer

主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);共病现象(Comorbidity);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.21873/invivo.11928

PMID 32354945

发布时间 2021-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

In vivo (Athens, Greece)

1451-1457页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian Cancer.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian Cancer.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

检索历史清除